With more than 25 years of experience, Kyriakos Mikellis is actively involved in the Cypriot healthcare environment as the President of the Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA) as well as the Country Lead Cyprus and Malta for Pfizer. He shares in this exclusive interview the important contribution global companies are bringing regarding the establishment of GeSY, the national healthcare system of Cyprus and to improving patients’ access to innovative medicines.
KEFEA is the association for research-based pharmaceutical companies in Cyprus. What are the main activities and current priorities of the association?
"We have tried all these years to convince other stakeholders and the decision making bodies that the new system must provide better services in comparison to what the people get today. I hope that this message got through and decisions will be taken towards that direction."
